These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12612105)

  • 21. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men.
    Halkitis PN; Parsons JT; Wolitski RJ; Remien RH
    AIDS Care; 2003 Feb; 15(1):89-102. PubMed ID: 12655837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy.
    Shuter J; Sarlo JA; Rode RA; Zingman BS
    HIV Clin Trials; 2009; 10(3):135-42. PubMed ID: 19632952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
    Mannheimer S; Thackeray L; Huppler Hullsiek K; Chesney M; Gardner EM; Wu AW; Telzak EE; Lawrence J; Baxter J; Friedland G;
    AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal analysis of HIV treatment adherence among men who have sex with men: a cognitive escape perspective.
    Du Bois SN; McKirnan DJ
    AIDS Care; 2012; 24(11):1425-31. PubMed ID: 22292512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engagement in HIV care and sexual transmission risk behavior among men who have sex with men using online social/sexual networking in Latin America.
    Magidson JF; Biello KB; Safren SA; Rosenberger JG; Novak DS; Mayer KH; Mimiaga MJ
    AIDS Care; 2015; 27(8):1055-62. PubMed ID: 25738655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.
    Bernstein KT; Liu KL; Begier EM; Koblin B; Karpati A; Murrill C
    Arch Intern Med; 2008 Jul; 168(13):1458-64. PubMed ID: 18625927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of HIV infection: how early and how intensive?].
    ter Hofstede HJ; Telgt DS; Koopmans PP
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):201-4. PubMed ID: 11219144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phenomenon of missing doses in a cohort of HIV patients with good adherence to highly active antiretroviral therapy.
    Lee SS; Ma K; Chu EK; Wong KH
    Int J STD AIDS; 2007 Mar; 18(3):167-70. PubMed ID: 17362548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].
    Salmon-Céron D; Deleuze J; Coste J; Guerin C; Ginsburg C; Blanche P; Finkielsztejn L; Pecqueux L; Chaput S; Gorin I; Sicard D
    Ann Med Interne (Paris); 2000 Jun; 151(4):297-302. PubMed ID: 10922958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS.
    Penedo FJ; Gonzalez JS; Dahn JR; Antoni M; Malow R; Costa P; Schneiderman N
    J Psychosom Res; 2003 Mar; 54(3):271-8. PubMed ID: 12614837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
    Ware NC; Wyatt MA; Tugenberg T
    Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence practices among people living with HIV.
    Adam BD; Maticka-Tyndale E; Cohen JJ
    AIDS Care; 2003 Apr; 15(2):263-74. PubMed ID: 12856347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors associated with adherence of highly active antiretroviral therapy among 386 HIV/AIDS patients in 3 provinces of China].
    Zhao WY; Yu HL; Ye SD; Wu YS; Wang M; Lao YF; He SH; Yang Y; Ling XM; Liu ZF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):334-8. PubMed ID: 27029365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A medication self-management program to improve adherence to HIV therapy regimens.
    Smith SR; Rublein JC; Marcus C; Brock TP; Chesney MA
    Patient Educ Couns; 2003 Jun; 50(2):187-99. PubMed ID: 12781934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beliefs about transmission risk and vulnerability, treatment adherence, and sexual risk behavior among a sample of HIV-positive men who have sex with men.
    Joseph HA; Flores SA; Parsons JT; Purcell DW
    AIDS Care; 2010 Jan; 22(1):29-39. PubMed ID: 20390478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.